Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Promethazine (PMZ) is an FDA-approved antihistaminergic drug that was identified as a potentially neuroprotective compound in the NINDS screening program. PMZ accumulates in brain mitochondria in vivo and inhibits Ca2+-induced mitochondrial permeability transition pore (PTP) in rat liver mitochondri...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2005-12-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996105001397 |
| id |
doaj-569e78ed730e42e9a81a69f5bcf78932 |
|---|---|
| record_format |
Article |
| spelling |
doaj-569e78ed730e42e9a81a69f5bcf789322021-03-20T04:51:27ZengElsevierNeurobiology of Disease1095-953X2005-12-01203701708Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicityCarine Cleren0Anatoly A. Starkov1Noel Y. Calingasan2Beverly J. Lorenzo3Junya Chen4M. Flint Beal5Corresponding author. Fax: +1 212 746 8276.; Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, Room A-501, New York, NY 10021, USAPromethazine (PMZ) is an FDA-approved antihistaminergic drug that was identified as a potentially neuroprotective compound in the NINDS screening program. PMZ accumulates in brain mitochondria in vivo and inhibits Ca2+-induced mitochondrial permeability transition pore (PTP) in rat liver mitochondria in vitro. We hypothesized that PMZ may have a protective effect in a mitochondrial toxin model of Parkinson's disease (PD). Mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) sustained a significant loss of dopaminergic neurons within the SNpc that was strongly attenuated by PMZ treatment. However, neither striatal MPP+ concentrations nor MPTP-induced inhibition of mitochondrial complex I were affected by PMZ treatment. In isolated mouse brain mitochondria, PMZ partially prevented and reversed MPP+-induced depolarization of membrane potential and inhibited the Ca2+-induced PTP in brain mitochondria. The sum of data indicates that PMZ is a strong neuroprotective agent capable of protecting dopaminergic neurons against MPTP toxicity in vivo.http://www.sciencedirect.com/science/article/pii/S0969996105001397PromethazineMPTPMPP+ParkinsonNeuroprotectionMitochondria |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Carine Cleren Anatoly A. Starkov Noel Y. Calingasan Beverly J. Lorenzo Junya Chen M. Flint Beal |
| spellingShingle |
Carine Cleren Anatoly A. Starkov Noel Y. Calingasan Beverly J. Lorenzo Junya Chen M. Flint Beal Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity Neurobiology of Disease Promethazine MPTP MPP+ Parkinson Neuroprotection Mitochondria |
| author_facet |
Carine Cleren Anatoly A. Starkov Noel Y. Calingasan Beverly J. Lorenzo Junya Chen M. Flint Beal |
| author_sort |
Carine Cleren |
| title |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| title_short |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| title_full |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| title_fullStr |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| title_full_unstemmed |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| title_sort |
promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| publisher |
Elsevier |
| series |
Neurobiology of Disease |
| issn |
1095-953X |
| publishDate |
2005-12-01 |
| description |
Promethazine (PMZ) is an FDA-approved antihistaminergic drug that was identified as a potentially neuroprotective compound in the NINDS screening program. PMZ accumulates in brain mitochondria in vivo and inhibits Ca2+-induced mitochondrial permeability transition pore (PTP) in rat liver mitochondria in vitro. We hypothesized that PMZ may have a protective effect in a mitochondrial toxin model of Parkinson's disease (PD). Mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) sustained a significant loss of dopaminergic neurons within the SNpc that was strongly attenuated by PMZ treatment. However, neither striatal MPP+ concentrations nor MPTP-induced inhibition of mitochondrial complex I were affected by PMZ treatment. In isolated mouse brain mitochondria, PMZ partially prevented and reversed MPP+-induced depolarization of membrane potential and inhibited the Ca2+-induced PTP in brain mitochondria. The sum of data indicates that PMZ is a strong neuroprotective agent capable of protecting dopaminergic neurons against MPTP toxicity in vivo. |
| topic |
Promethazine MPTP MPP+ Parkinson Neuroprotection Mitochondria |
| url |
http://www.sciencedirect.com/science/article/pii/S0969996105001397 |
| work_keys_str_mv |
AT carinecleren promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity AT anatolyastarkov promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity AT noelycalingasan promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity AT beverlyjlorenzo promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity AT junyachen promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity AT mflintbeal promethazineprotectsagainst1methyl4phenyl1236tetrahydropyridineneurotoxicity |
| _version_ |
1724211906435088384 |